Congenital hypothyroidism and the importance of universal newborn screening

Area of Science:

• Pediatrics
• Endocrinology
• Genetics

Background:

• Congenital hypothyroidism (CH) is a leading preventable cause of intellectual disability in newborns.
• Clinical signs of CH are often subtle and not apparent during the neonatal period, delaying diagnosis and treatment.
• Early intervention is crucial to prevent irreversible cognitive impairment.

Purpose of the Study:

• To review the epidemiology, etiology, classification, clinical features, and diagnosis of primary CH.
• To outline the management of abnormal newborn screening results for CH.
• To discuss the treatment and prognosis of primary CH and emphasize the importance of universal newborn screening.

Main Methods:

• Comprehensive review of current literature on congenital hypothyroidism.
• Analysis of data regarding screening, diagnosis, and management protocols.
• Synthesis of information on the impact of early detection and treatment.

Main Results:

• Universal newborn screening (NS) is highly effective in identifying CH cases early.
• Timely treatment initiated after screening significantly improves neurodevelopmental outcomes.
• Understanding the diverse etiologies and classifications of CH is essential for tailored management.

Conclusions:

• Universal newborn screening is a critical public health strategy for preventing mental retardation associated with CH.
• Early diagnosis and treatment of CH are paramount for ensuring normal cognitive development in affected children.
• Continued research into CH etiology and improved screening protocols can further enhance outcomes.